MaxCyte, Inc. (MXCT): A Bull Case Theory

We came across a bullish thesis on MaxCyte, Inc. (MXCT) on Substack by OppCost. In this article, we will summarize the bulls’ thesis on MXCT. MaxCyte, Inc. (MXCT)'s share was trading at $2.355 as of May 9^th.

[caption id="attachment_1238816" align="aligncenter" width="768"] A scientist in a lab conducting research on cell-based therapeutics and biotechnology.[/caption]

MaxCyte, Inc. is a commercial-stage cell-engineering company with a strong strategic position in the rapidly growing cell and gene therapy (CGT) industry. The company's core offering, the ExPERT™ platform,...